Lenalidomide Plus Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma: A Phase 1 / 2 Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Study of Single Agent Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
IFM2009-02-Pomalidomide and Dexamethasone Phase 2 Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide + Azacitidine for Adaptive Immunotherapy -> Auto SCT in Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Study of Bendamustine, Velcade and Dexamethasone in the Treatment of Elderly Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
MSC and HSC Coinfusion in Mismatched Minitransplants
- Status
- TERMINATED
- Phase
- PHASE2
Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection
- Status
- UNKNOWN
- Phase
- NA
Expanded Natural Killer (NK) Cells for Multiple Myeloma Study
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of the Combination Vorinostat With Lenalidomide, Bortezomib and Dexamethasone for Patients With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Trial of an Augmented Mobilization Strategy With Plerixafor (Mozobil®) in a Population at Risk for Poor Stem Cell Mobilization
- Status
- COMPLETED
- Phase
- PHASE2
A Retreatment Study With Bortezomib for Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed, Previously Untreated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Observational Study of the Effects Intravenous Bortezomib Has on Osteoblast (Cell That is Responsible for Bone Formation) Activity in Multiple Myeloma Patients.
- Status
- COMPLETED
- Phase
- N/A
A Study of a Human Anti-Intercellular Adhesion Molecule-1 Monoclonal Antibody, in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Study to Determine the Maximum Tolerated Dose and Evaluate the Efficacy and Safety of CEP-18770 (Delanzomib) in Patients With Relapsed Multiple Myeloma Refractory to the Most Recent Therapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Quality of Life in Multiple Myeloma Patients Treated With Bortezomib
- Status
- COMPLETED
- Phase
- N/A
Lenalidomide/Low-dose Dexamethasone in Combination With Continuous Oral Cyclophosphamide Compared to Lenalidomide/Low-dose Dexamethasone Combined With Single Cyclophosphamide Doses IV in Patients With Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients
- Status
- COMPLETED
- Phase
- PHASE2